MEDVI GLP

MEDVi is a telehealth-based weight loss program that offers personalized GLP-1 (glucagon-like peptide-1) treatments, such as compounded Semaglutide and Tirzepatide, to help individuals achieve sustainable weight loss. These medications work by regulating appetite, improving metabolism, and enhancing satiety, addressing the root causes of obesity. MEDVi aims to make these treatments accessible and affordable, providing a convenient alternative to traditional weight loss methods. The goal of the program is to help people who might not be able to afford GLP-1 medications.